Evidence map›Paper›PMID 33489747›Full record

ArticleRespiratory medicine case reports2021

A case of allergic bronchopulmonary aspergillosis with marked peripheral blood eosinophilia successfully treated with benralizumab.

Kazuya Tsubouchi, Masako Arimura-Omori, Shigesato Inoue, Yuki Okamatsu, Katsuhiro Inoue, Taishi Harada

Open access · goldAbstract readCase Reports
In one paragraph

Article in Respiratory medicine case reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
1.2field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 12 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Kazuya TsubouchiDepartment of Respiratory Medicine, Japan Community Health Care Organization Kyushu Hospital, Fukuoka, Japan.
Masako Arimura-OmoriDepartment of Respiratory Medicine, Japan Community Health Care Organization Kyushu Hospital, Fukuoka, Japan.
Shigesato InoueDepartment of Respiratory Medicine, Japan Community Health Care Organization Kyushu Hospital, Fukuoka, Japan.
Yuki OkamatsuDepartment of Respiratory Medicine, Japan Community Health Care Organization Kyushu Hospital, Fukuoka, Japan.
Katsuhiro InoueDepartment of Respiratory Medicine, Japan Community Health Care Organization Kyushu Hospital, Fukuoka, Japan.
Taishi HaradaDepartment of Respiratory Medicine, Japan Community Health Care Organization Kyushu Hospital, Fukuoka, Japan.
Kyushu Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We herein report a case of allergic bronchopulmonary aspergillosis (ABPA) with marked eosinophilia and high attenuation mucus (HAM) on chest computed tomography (CT), which demonstrated a rapid and remarkable improvement with benralizumab treatment. A 67-year-old Japanese woman, who was diagnosed with asthma at the age of 64 years, was admitted with dyspnea. Her blood test results showed marked eosinophilia (peripheral blood eosinophil count 24403/μL) and elevated serum IgE levels. Chest CT also revealed ground-glass opacity. Sputum cytology detected filamentous fungi, suggesting an infection with

Indexed as

Allergic bronchopulmonary aspergillosisBenralizumabEosinophiliaHigh-attenuation mucus

Identifiers

PMID33489747
PMCPMC7807250
OpenAlexW3120731540

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.